Pekeliling Berkenaan Pengemaskinian Guidance Document and Guidelines for Registration of Biosimilars in Malaysia

NPRA Banner

Pekeliling Berkenaan Pengemaskinian Guidance Document and Guidelines for Registration of Biosimilars in Malaysia

: Posted By Lisa Assakina; 18 Januari 2024; Jumlah paparan: 2675

Pekeliling

Tarikh

Pekeliling Berkenaan Pengemaskinian Guidance Document and Guidelines for Registration of Biosimilars in Malaysia

Lampiran A - Guideline for Facilitated Registration Pathway (FRP), Revision 1, 2023

16 November 2023

Rating:

( 0 Rating )

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

Phone: +603-7883 5400

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

NPRA Product Status

Site Last Modified

Last Modified: Khamis 31 Oktober 2024, 08:00:16.

Online Services

QUEST3+ System

NPRA Support System

Online Public Engagement

Online Procurement Announcement

Pekeliling Berkenaan Pengemaskinian Guidance Document and Guidelines for Registration of Biosimilars in Malaysia

More Links

More Links

DISCLAIMER

Site Last Modified

Online Services

Search

Choose Your Language

Regulation Basics

Menu Utama